| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/13/1993 | US5202351 Treating hyperlipemia, atherosclerosis |
| 04/13/1993 | US5202029 High performance liquid chromatography |
| 04/11/1993 | CA2080110A1 Organic compounds |
| 04/10/1993 | CA2080054A1 17beta-substituted aza-androstane derivatives |
| 04/10/1993 | CA2079428A1 Pharmaceutical compounds |
| 04/08/1993 | WO1993007155A1 Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them |
| 04/08/1993 | DE4132701A1 Verfahren zur herstellung von staerkeabbauprodukten mit einer engen molekulargewichtsverteilung A process for preparing staerkeabbauprodukten having a narrow molecular weight distribution |
| 04/08/1993 | CA2097608A1 Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them |
| 04/07/1993 | CN1070642A Process for preparation of anti-hypercholesterolemic |
| 04/06/1993 | US5200424 Use of 10-membered ring lactones as lipid regulators |
| 04/06/1993 | US5200342 Squalene synthetase inhibitors and processes therefrom |
| 04/06/1993 | CA1315674C Pharmaceutical compositions containing at least one bicyclic aromatic derivative as an active ingredient |
| 04/01/1993 | WO1993006223A1 Viral recombinant vectors for expression in muscle cells |
| 04/01/1993 | WO1993006131A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 04/01/1993 | WO1993005823A1 Bone-growth-stimulating composition |
| 04/01/1993 | WO1993005808A1 Bone-growth-stimulating composition |
| 04/01/1993 | WO1993005751A2 Osteogenic proteins in the treatment of bone deseases |
| 04/01/1993 | CA2116033A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 03/31/1993 | EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof |
| 03/31/1993 | EP0534304A1 Cycloalkylated polyethylenimines and their use as hypolipemic agents |
| 03/31/1993 | EP0533898A1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| 03/31/1993 | EP0533724A1 Calcium citrate malate composition. |
| 03/31/1993 | EP0407461B1 Novel cyclopentano-vitamin d analogs |
| 03/31/1993 | CN1070408A Trifluoromethylbenzylphosphonates useful in treating osteoperosis |
| 03/30/1993 | US5198466 Oxysulfonyl urea acat inhibitors |
| 03/30/1993 | US5198250 Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using |
| 03/30/1993 | CA1315476C Vanadyl organo-mineral compound, method for obtaining such a compound, pharmaceutical composition containing this organo-mineral compound |
| 03/30/1993 | CA1315471C Pyridine-2,4- and 2,5-dicarboxylic acid derivatives, a process for their preparation, the use thereof, and medicaments based on these compounds |
| 03/30/1993 | CA1315276C Castanospermine esters and glycosides |
| 03/30/1993 | CA1315149C Process for the preparation of a sterilised casein-based liquid composition |
| 03/27/1993 | CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them |
| 03/24/1993 | EP0533266A1 Benzanilide derivatives as 5-HT1D antagonists |
| 03/24/1993 | EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity |
| 03/23/1993 | US5196412 Treatment of excess calcium |
| 03/23/1993 | CA1314906C Didehydro vitamin d -derivatives |
| 03/23/1993 | CA1314882C Substituted piperidines or azepines, the preparation thereof and their application in therapy |
| 03/23/1993 | CA1314873C 3-demethylmevalonic acid derivatives, a process for their preparation, pharmaceutical products based on these compounds, their use and intermediates |
| 03/23/1993 | CA1314871C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents |
| 03/23/1993 | CA1314870C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents |
| 03/22/1993 | CA2078589A1 Alkylated polyethyleneimine derivatives, a process for the preparation thereof, the use thereof as pharmaceuticals, and pharmaceutical products |
| 03/19/1993 | CA2078506A1 Benzanilide derivatives |
| 03/18/1993 | WO1993005084A1 Composition and method for reducing cholesterol concentration |
| 03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
| 03/18/1993 | WO1993004699A1 Therapeutic method for iddm |
| 03/18/1993 | WO1993004694A1 A method for treatment of patients with chronic liver disease |
| 03/18/1993 | WO1993004690A1 Method for the treatment of the complications and pathology of diabetes |
| 03/18/1993 | DE4130546A1 Knochenwachstumsfoerdernde zusammensetzung Knochenwachstumsfoerdernde composition |
| 03/18/1993 | DE4130545A1 Knochenwachstumsfoerdernde zusammensetzung Knochenwachstumsfoerdernde composition |
| 03/18/1993 | CA2116431A1 Composition and method for reducing cholesterol concentration |
| 03/17/1993 | EP0532027A1 Cyclic nitrones, their preparation and pharmaceutical compositions containing them |
| 03/17/1993 | EP0360821B1 Pharmaceutical compositions for treating adrenoleukodystrophy |
| 03/17/1993 | CN1020098C Production for thiolactam-N-acetic acid derivatives |
| 03/17/1993 | CN1020093C 1-phenyl -3-naphthalenyloxypropanamines |
| 03/16/1993 | US5194585 Vasoactive peptides |
| 03/16/1993 | US5194581 Biodegradable poly(phosphoesters) |
| 03/16/1993 | US5194437 Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders |
| 03/16/1993 | US5194431 24-cyclopropane vitamin D derivatives |
| 03/16/1993 | US5194259 Plant extracts |
| 03/10/1993 | EP0531253A1 N-substituted aminomethanediphosphonic acids |
| 03/10/1993 | EP0531119A1 N,N',N'-trisubstituted -5-bis-aminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA: cholesterol-acyl transferase |
| 03/10/1993 | EP0530862A2 Dermatological cosmetic composition containing polyvitamined mixtures |
| 03/10/1993 | EP0530320A1 Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds |
| 03/10/1993 | EP0530242A1 Compounds |
| 03/10/1993 | EP0530198A1 Heterocyclic compounds as aldose reductase inhibitors |
| 03/10/1993 | EP0525002A4 2(5h)-furanones substituted in the 3 position, as ca?2+ channel antagonists and anti-inflammatory agents |
| 03/10/1993 | EP0382772B1 Reduction of low density lipoproteins in biological fluids |
| 03/10/1993 | CN1069737A Insulin analogs |
| 03/10/1993 | CA2050948A1 5-benzyl substituted-benzimidazo-line-2-thion derivatives and a process for preparing the same |
| 03/09/1993 | US5192790 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis |
| 03/09/1993 | US5192577 Nutritional composition and a process for its production |
| 03/09/1993 | CA1314233C Calcium supplements |
| 03/09/1993 | CA1314232C Amino acid composition for parenteral nutritional support |
| 03/09/1993 | CA1314230C Mixtures for treating hypercholesterolemia |
| 03/09/1993 | CA1314229C Treatment of lipoprotein disorders associated with cholesterol metabolism |
| 03/09/1993 | CA1314217C Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| 03/04/1993 | WO1993004373A1 Calcium receptor active molecules |
| 03/04/1993 | WO1993004073A1 Phosphorus-substituted isoprenoid derivative |
| 03/04/1993 | WO1993004067A1 Hypoglycemic n-sulfonyl-tetrahydro-[1,3]-dioxepino[5,6-b]azirines |
| 03/04/1993 | WO1993004035A1 New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them |
| 03/04/1993 | WO1993003746A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives |
| 03/04/1993 | WO1993003734A1 Method for lowering blood lipid levels |
| 03/04/1993 | WO1992020650A3 Phosphite-borane compounds, and method of making and using the same |
| 03/04/1993 | CA2115849A1 Phosphorus-containing isoprenoid derivatives |
| 03/04/1993 | CA2115675A1 Method for lowering blood lipid levels |
| 03/04/1993 | CA2115349A1 New 3,5-di-tert-butyl-4-hydroxyphenyl derivatives, processes for their preparation and medicaments |
| 03/04/1993 | CA2115270A1 The use of the peptidoglycan monomer (pgm), its n-acyl derivatives, and its metal complexes in the preparation of medicaments for the correction of the immunosuppressive and hepatosuppressive states of the organism |
| 03/04/1993 | CA2115269A1 N-sulfonyl-tetrahydro-[1,3]-dioxepino[5,6-b]azirines, methods and intermediates for their preparation, and their use |
| 03/03/1993 | EP0529854A2 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors |
| 03/03/1993 | EP0529702A1 Dihydropyridine derivatives, their preparation and their use |
| 03/03/1993 | EP0529226A1 p-Oxybenzoic acid derivatives, process for preparing them and their use as medicaments |
| 03/03/1993 | EP0528951A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
| 03/03/1993 | EP0528862A1 Composition for solid pharmaceutical preparations containing vitamin d 3? derivative and process for preparation thereof |
| 03/03/1993 | EP0512076A4 Method of treating cancer using structured lipids |
| 03/02/1993 | US5191093 Process for preparing crystalline calcium pseudomonate |
| 03/02/1993 | US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions |
| 03/02/1993 | US5190948 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes |
| 03/02/1993 | US5190939 Antihypoxic |
| 03/02/1993 | US5190755 Nutrient composition and method for the preparation thereof |
| 02/28/1993 | CA2076801A1 N-substituted aminomethanediphosphonic acids |
| 02/24/1993 | EP0528734A1 Thiazolidin-2,4-dione derivatives, process for their preparation and pharmaceutical compositions containing them |